An Exploratory, Uncontrolled, Open-labeled Trial to Evaluate the Effect of FMX-8 Treatment for Anemia in Patients With Chronic Kidney Disease (CKD), Stage 4 or 5

Trial Profile

An Exploratory, Uncontrolled, Open-labeled Trial to Evaluate the Effect of FMX-8 Treatment for Anemia in Patients With Chronic Kidney Disease (CKD), Stage 4 or 5

Discontinued
Phase of Trial: Phase 0

Latest Information Update: 05 Jun 2015

At a glance

  • Drugs FMX 8 (Primary)
  • Indications Anaemia
  • Focus Therapeutic Use
  • Sponsors FerruMax Pharmaceuticals
  • Most Recent Events

    • 02 Jun 2015 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
    • 24 Nov 2014 According to the ClinicalTrials.gov record, status changed from not yet recruiting to recruiting.
    • 04 Sep 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top